← Back to Search

Behavioral Intervention

ERP combined with Improv Group Therapy for Obsessive-Compulsive Disorder

N/A

Recruiting

Led By Carolyn Rodriguez, MD, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years of age

Clinical diagnosis of obsessive-compulsive disorder (OCD)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and up to 12 weeks

Awards & highlights

Study Summary

"This trial aims to test a new group therapy for adults with OCD."

Who is the study for?

This trial is for adults over 18 who can speak and understand English and have been diagnosed with Obsessive-Compulsive Disorder (OCD). It's not suitable for individuals currently having suicidal thoughts or those with medical or psychiatric conditions that could affect their participation.Check my eligibility

What is being tested?

The study is testing a new group therapy method that combines Exposure Response Prevention (ERP) with improvisational group psychotherapy to see if it helps people with OCD.See study design

What are the potential side effects?

Since this is a psychotherapy intervention, there may not be physical side effects like in drug trials. Participants might experience emotional discomfort or anxiety as they confront OCD-related fears during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with obsessive-compulsive disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)

Secondary outcome measures

Change in Intolerance of Uncertainty Score

Trial Design

1Treatment groups

Experimental Treatment

Group I: ERP combined with Improv Group TherapyExperimental Treatment2 Interventions

Participants will attend 90-minute ERP + improv group therapy sessions for 12 consecutive weeks. They will also complete homework between sessions, answer questions, and complete questionnaires.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,338 Total Patients Enrolled

15 Trials studying Obsessive-Compulsive Disorder

1,391 Patients Enrolled for Obsessive-Compulsive Disorder

Carolyn Rodriguez, MD, PhDPrincipal InvestigatorStanford University

5 Previous Clinical Trials

256 Total Patients Enrolled

2 Trials studying Obsessive-Compulsive Disorder

240 Patients Enrolled for Obsessive-Compulsive Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for participants in this research study?

"As detailed on clinicaltrials.gov, this study is actively seeking eligible individuals. The trial was first listed on 2/9/2024 and last revised on the same date."

Answered by AI

What is the upper limit for patient participation in this particular research endeavor?

"Yes, the details on clinicaltrials.gov suggest that this investigation is presently enlisting participants. It was originally publicized on February 9th, 2024 and last revised on the same day. The research study aims to recruit 12 individuals from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ERP Plus Improv Group Therapy for OCD (IMPROVE Study)

Carolyn Rodriguez 2024. "ERP Plus Improv Group Therapy for OCD (IMPROVE Study)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06265233.

All > Obsessive Compulsive Disorder > Sacramento